{"id":22902,"date":"2026-09-15T11:58:21","date_gmt":"2026-09-15T09:58:21","guid":{"rendered":"https:\/\/mic-site.labiux.com\/zalu-nelabveliga-ietekme-uz-gremosanas-traktu-un-palidzibas-iespejas\/"},"modified":"2026-10-16T22:27:53","modified_gmt":"2026-10-16T19:27:53","slug":"zalu-nelabveliga-ietekme-uz-gremosanas-traktu-un-palidzibas-iespejas","status":"publish","type":"post","link":"https:\/\/farmacija-mic.lv\/en\/zalu-nelabveliga-ietekme-uz-gremosanas-traktu-un-palidzibas-iespejas\/","title":{"rendered":"Z\u0101\u013cu nelabv\u0113l\u012bga ietekme uz gremo\u0161anas traktu  un pal\u012bdz\u012bbas iesp\u0113jas"},"content":{"rendered":"<div class=\"wp-block-labiux-legacy-html legacy-content\">\n<p>Aptuveni 40% z\u0101\u013cu nev\u0113lamo blak\u0146u skar gremo\u0161anas traktu. J\u0101\u0146em v\u0113r\u0101, ka gremo\u0161anas trakta darb\u012bbas trauc\u0113jumus var izrais\u012bt ne tikai peror\u0101li lietojamas z\u0101les, bet ar\u012b medikamenti, kas ievad\u012bti cit\u0101 veid\u0101.<\/p>\n<p><strong>Iesp\u0113jamie meh\u0101nismi:<\/strong><br \/>\n\u2022 paredzama z\u0101\u013cu farmakolo\u0123isk\u0101s darb\u012bbas izpausme;<br \/>\n\u2022 tie\u0161s g\u013cot\u0101das vai audu boj\u0101jums;<br \/>\n\u2022 zarnu mikrobiotas izmai\u0146as;<br \/>\n\u2022 iedarb\u012bba \u0101rpus gremo\u0161anas trakta ar sekund\u0101ru ietekmi uz KZT;<br \/>\n\u2022 citi meh\u0101nismi.<\/p>\n<h3>Mukoz\u012bts<\/h3>\n<p>\nCitotoksisku l\u012bdzek\u013cu lieto\u0161ana aptuveni 20\u201370% pacientu var izrais\u012bt mukoz\u012btu. Izpausmes parasti s\u0101kas 5\u201310 dienas p\u0113c \u0137\u012bmijterapijas s\u0101k\u0161anas un var ilgt 7\u201314 vai pat l\u012bdz 28 dien\u0101m. Mukoz\u012btu var izrais\u012bt ar\u012b citi medikamenti, piem\u0113ram, kortikostero\u012bdi, metotreks\u0101ts, pregabal\u012bns, aciklov\u012brs, prets\u0113n\u012b\u0161u l\u012bdzek\u013ci, DPP-4 inhibitori, retino\u012bdi, NPL, nikot\u012bns u.c.<br \/>\nGalvenie simptomi ir s\u0101pes mut\u0113, asi\u0146o\u0161ana, sausums, aps\u0101rtums, mutes g\u013cot\u0101das piet\u016bkums, ierobe\u017eota mutes atv\u0113r\u0161ana, diz\u00adartrija, disf\u0101gija un gar\u0161as trauc\u0113jumi.<br \/>\n<strong>Terapijas iesp\u0113jas<\/strong><br \/>\n\u2022 Mukoz\u012bts parasti ir pa\u0161limit\u0113jo\u0161s. Ja iesp\u0113jams, j\u0101apsver provoc\u0113jo\u0161\u0101 medikamenta lieto\u0161anas p\u0101rtrauk\u0161ana.<br \/>\n\u2022 Ieteicama r\u016bp\u012bga mutes dobuma un zobu higi\u0113na.<br \/>\n\u2022 Lok\u0101la un peror\u0101la prets\u0101pju terapija.<br \/>\n\u2022 Mutes dobuma dekontamin\u0101cija, tostarp antibakteri\u0101lu un prets\u0113n\u012b\u0161u skalo\u0161anas l\u012bdzek\u013cu lieto\u0161ana.<br \/>\n\u2022 Pacientiem j\u0101izvair\u0101s no sk\u0101bas, pikantas, s\u0101\u013cas, rupjas un sausas p\u0101rtikas.<br \/>\n\u2022 Mutes dobums j\u0101uztur mitrs, regul\u0101ri malkojot \u016bdeni, k\u0101 ar\u012b izmantojot ledus gabali\u0146us vai bezcukura saldumus.<br \/>\n\u2022 Smagos gad\u012bjumos g\u013cot\u0101das boj\u0101jumi un stipras s\u0101pes var b\u016btiski apgr\u016btin\u0101t uztura uz\u0146em\u0161anu, t\u0101d\u0113\u013c var b\u016bt nepiecie\u0161ama \u0161\u012bs probl\u0113mas risin\u0101\u0161ana.\n<\/p>\n<h3>Mutes g\u013cot\u0101das \u010d\u016blas<\/h3>\n<p>\nMutes g\u013cot\u0101das \u010d\u016blas var izrais\u012bt holinol\u012btiskie l\u012bdzek\u013ci, kortikostero\u012bdi, NPL, antibakteri\u0101lie l\u012bdzek\u013ci, pretdiab\u0113ta l\u012bdzek\u013ci, antihipertens\u012bvie l\u012bdzek\u013ci, k\u0101liju saturo\u0161i prepar\u0101ti, pankreat\u012bns, antiagreganti u.c.<br \/>\n\u0160\u0101du boj\u0101jumu risks ir \u012bpa\u0161i augsts pacientiem, kuri z\u0101les, kas paredz\u0113tas t\u016bl\u012bt\u0113jai nor\u012b\u0161anai, ilgsto\u0161i tur mut\u0113.<br \/>\nP\u0113c z\u0101\u013cu lieto\u0161anas p\u0101rtrauk\u0161anas, nomai\u0146as vai devas samazin\u0101\u0161anas \u010d\u016blas var izzust 1\u20132 ned\u0113\u013cu laik\u0101.<br \/>\nPapildu ieteikumi ir l\u012bdz\u012bgi k\u0101 mukoz\u012bta gad\u012bjum\u0101: r\u016bp\u012bga mutes dobuma higi\u0113na, izvair\u012b\u0161an\u0101s no kairino\u0161as p\u0101rtikas, nepiecie\u0161am\u012bbas gad\u012bjum\u0101 prets\u0101pju terapija un pietiekama \u0161\u0137idruma uz\u0146em\u0161ana.\n<\/p>\n<h3>Kserostomija<\/h3>\n<p>\nKserostomiju jeb sausu muti var izrais\u012bt vair\u0101k nek\u0101 500 medikamentu. Ilgsto\u0161a kse\u00adrostomija var veicin\u0101t s\u0113n\u012b\u0161infekcijas att\u012bst\u012bbu, dedzino\u0161u saj\u016btu mut\u0113, zobu kariesu un s\u0101pes. Vairum\u0101 gad\u012bjumu kserostomija ir atgriezeniska p\u0113c farmakoterapijas korekcijas.<br \/>\nKserostomiju var izrais\u012bt, piem\u0113ram, diur\u0113tiskie l\u012bdzek\u013ci, pirm\u0101s paaudzes antihistam\u012bna l\u012bdzek\u013ci, antidepresanti ar M-hol\u012bnblo\u0137\u0113jo\u0161u darb\u012bbu (piem\u0113ram, amitriptil\u012bns), inhal\u0113jamie M-hol\u012bnblokatori (ipratropijs, tiotropijs), inhal\u0113jamie \u03b2\u2082 agonisti (salbutamols, formoterols, salmeterols), klonid\u012bns, opio\u012bdi, rizatript\u0101ns, inhal\u0113jamie glikokortikostero\u012bdi, benzodiazep\u012bni, AKE inhibitori u.c.<br \/>\n<strong>Terapijas iesp\u0113jas<\/strong><br \/>\n\u2022 Ja iesp\u0113jams, provoc\u0113jo\u0161o medikamentu aizst\u0101j ar citu l\u012bdzv\u0113rt\u012bgu terapiju.<br \/>\n\u2022 Ko\u0161\u013c\u0101jam\u0101s gumijas lieto\u0161ana, lai stimul\u0113tu siekalu izdal\u012b\u0161anos.<br \/>\n\u2022 Bezcukura konfek\u0161u s\u016bk\u0101\u0161ana.<br \/>\n\u2022 \u201cM\u0101ksl\u012bgo siekalu\u201d lieto\u0161ana (var satur\u0113t karboksimetilcelulozi, hidroksi\u00adetilcelulozi, glicer\u012bnu, sorb\u012btu vai citas mitrino\u0161as vielas).<br \/>\n\u2022 Mutes dobuma skalo\u0161ana p\u0113c medikamenta lieto\u0161anas.<br \/>\n\u2022 \u0112dienrei\u017eu laik\u0101 ieteicams uz\u0146emt pietiekami daudz \u0161\u0137idruma; priek\u0161roka dodama m\u012bkstiem un \u0161\u0137idriem \u0113dieniem.<br \/>\n\u2022 Telpu gaisa mitrin\u0101\u0161ana.<br \/>\n\u2022 Sm\u0113\u0137\u0113\u0161anas atme\u0161ana.<br \/>\n\u2022 R\u016bp\u012bga mutes dobuma higi\u0113na p\u0113c katras \u0113dienreizes.\n<\/p>\n<h3>Table\u0161u lieto\u0161anas izrais\u012bts ezofag\u012bts<\/h3>\n<p>\nVisbie\u017e\u0101k ezofag\u012bts izpau\u017eas ar s\u0101p\u0113m aiz kr\u016b\u0161u kaula un odinof\u0101giju (s\u0101p\u012bgu r\u012b\u0161anu). Da\u017eos gad\u012bjumos s\u0101pes var b\u016bt tik stipras, ka pacientam ir gr\u016bti nor\u012bt pat siekalas. Reti nov\u0113ro hematem\u0113zi, s\u0101pes v\u0113der\u0101 un \u0137erme\u0146a masas mazin\u0101\u0161anos.<br \/>\nSimptomi p\u0113c table\u0161u lieto\u0161anas parasti rodas tr\u012bs dienu laik\u0101, ta\u010du da\u017ek\u0101rt tie var att\u012bst\u012bties jau da\u017eu stundu laik\u0101 p\u0113c z\u0101\u013cu lieto\u0161anas.<br \/>\nZ\u0101les, kas var izrais\u012bt lok\u0101lu bar\u012bbas vada boj\u0101jumu, atsevi\u0161\u0137os gad\u012bjumos var izrais\u012bt ar\u012b ku\u0146\u0123a g\u013cot\u0101das boj\u0101jumu, tostarp gastr\u012btu. Vairums z\u0101\u013cu izrais\u012bta bar\u012bbas vada boj\u0101juma izpausmju izz\u016bd bez specifiskas \u0101rst\u0113\u0161anas da\u017eu dienu laik\u0101 p\u0113c provoc\u0113jo\u0161\u0101 medikamenta lieto\u0161anas p\u0101rtrauk\u0161anas.<br \/>\n<strong>Antibiotikas<\/strong> (\u012bpa\u0161i tetracikl\u012bni) rada aptuveni 50% z\u0101\u013cu izrais\u012bta ezofag\u012bta gad\u012bjumu un ir viena no bie\u017e\u0101k\u0101m ezofag\u012bta etiolo\u0123ij\u0101m gados jaun\u0101kiem pieaugu\u0161ajiem.<br \/>\n<strong>NPL <\/strong>(\u012bpa\u0161i aspir\u012bns un naproks\u0113ns) rada maz\u0101k nek\u0101 10% z\u0101\u013cu izrais\u012bta ezofag\u012bta gad\u012bjumiem.<br \/>\n<strong>Bisfosfon\u0101ti<\/strong> \u2013 tie\u0161i \u0161iem medikamentiem viena no pirm\u0101m stingr\u0101m rekomend\u0101cij\u0101m bija saist\u012bta ar pareizu lieto\u0161anu, lai nepie\u013cautu bar\u012bbas vada blaknes: tabletei j\u0101uzdzer gl\u0101ze \u016bdens un vismaz 30 min\u016btes j\u0101paliek vertik\u0101l\u0101 st\u0101vokl\u012b, lai tablete nepaliek saskar\u0113 ar bar\u012bbas vadu.<br \/>\n<strong>Citi medikamenti<\/strong>, kas var izrais\u012bt \u0161o blakni: antihipertens\u012bvie l\u012bdzek\u013ci (kaptoprils, nifedip\u012bns), teofil\u012bns\/aminofil\u012bns, vitam\u012bni un miner\u0101lvielas (C vitam\u012bns, dzelzs, kalcijs, k\u0101lija hlor\u012bds), kortikostero\u012bdi, peror\u0101lie kontracepcijas l\u012bdzek\u013ci, varfar\u012bns, retino\u012bdi u.c.<br \/>\n<strong>Riska faktori<\/strong><br \/>\n\u2022 Neatbilsto\u0161a pacienta \u0137erme\u0146a poz\u012bcija z\u0101\u013cu lieto\u0161anas laik\u0101 un p\u0113c t\u0101s.<br \/>\n\u2022 Liela tablete.<br \/>\n\u2022 Z\u0101l\u0113m tiek uzdzerts par maz \u0161\u0137idruma.<br \/>\n\u2022 Bar\u012bbas vada motorikas trauc\u0113jumi vai anatomiskas izmai\u0146as, piem\u0113ram, bar\u012bbas vada strikt\u016bra.<\/p>\n<p><strong>1. tabula.<\/strong> Table\u0161u lieto\u0161anas izrais\u012bta ezofag\u012bta \u0101rst\u0113\u0161ana un profilakse\n<\/p>\n<p><strong>Terapija<\/strong><strong>Profilakse<\/strong>Provoc\u0113jo\u0161\u0101 medikamenta lieto\u0161anas p\u0101rtrauk\u0161ana vai, ja iesp\u0113jams, t\u0101 ievades ce\u013ca mai\u0146a.<br \/>\nKu\u0146\u0123a sk\u0101bes sekr\u0113cijas nom\u0101k\u0161ana, lietojot protonu s\u016bk\u0146a inhibitoru (PSI).<br \/>\nAtbalsto\u0161\u0101 apr\u016bpe: pacientiem ar smagu odinof\u0101giju var b\u016bt nepiecie\u0161ama \u012bslaic\u012bga parenter\u0101la \u0161\u0137idruma ievad\u012b\u0161ana vai smagos gad\u012bjumos parenter\u0101la baro\u0161ana.\u00a0Ja iesp\u0113jams, j\u0101maina z\u0101\u013cu ievades ce\u013c\u0161.<br \/>\nJ\u0101nov\u0113r\u0161 predispon\u0113jo\u0161ie faktori.<br \/>\nTabletes j\u0101lieto, pacientam atrodoties vertik\u0101l\u0101 st\u0101vokl\u012b.<br \/>\nLietojot z\u0101les, j\u0101uzdzer pietiekams daudzums \u0161\u0137idruma \u2013 vismaz 100 ml vairumam z\u0101\u013cu un aptuveni 170 ml z\u0101l\u0113m, kas rada ezofag\u012bta risku.<br \/>\nP\u0113c table\u0161u lieto\u0161anas ieteicams palikt vertik\u0101l\u0101 st\u0101vokl\u012b vismaz 10 min\u016btes, bet, lietojot z\u0101les, kas rada ezofag\u012bta risku, vismaz 30 min\u016btes.<\/p>\n<h3>Peptiskas \u010d\u016blas<\/h3>\n<p>\nNPL rada liel\u0101ko peptisku \u010d\u016blu att\u012bst\u012bbas risku. Vid\u0113jais relat\u012bvais risks nekomplic\u0113tas vai komplic\u0113tas peptiskas \u010d\u016blas att\u012bst\u012bbai NPL lietot\u0101jiem ir aptuveni 4\u20135 reizes liel\u0101ks nek\u0101 cilv\u0113kiem, kuri NPL nelieto.<br \/>\nNPL lieto\u0161anas laik\u0101 pacientam var att\u012bst\u012bties ar\u012b citi ku\u0146\u0123a un zarnu trakta (KZT) simptomi \u2013 no viegliem, piem\u0113ram, dispepsijas, gastroezofage\u0101l\u0101 atvi\u013c\u0146a, sliktas d\u016b\u0161as un s\u0101p\u0113m v\u0113der\u0101, l\u012bdz smagiem, piem\u0113ram, KZT asi\u0146o\u0161anai, perfor\u0101cijai un gastr\u012btam.<br \/>\n<strong>Peror\u0101lu z\u0101\u013cu formu apvalks vai cita ievad\u012b\u0161anas metode piln\u012bgi nepasarg\u0101 no KZT boj\u0101juma vai asi\u0146o\u0161anas riska.<\/strong><\/p>\n<p><strong>Ar pacientu saist\u012bti riska faktori<\/strong><br \/>\n\u2022 Vecums.<br \/>\n\u2022 KZT asi\u0146o\u0161ana anamn\u0113z\u0113.<br \/>\n\u2022 Past\u0101vo\u0161a H. pylori infekcija (dati par t\u0101s noz\u012bmi NPL izrais\u012btu KZT komplik\u0101ciju riska palielin\u0101\u0161an\u0101 ir pretrun\u012bgi).<br \/>\n\u2022 P\u0101rm\u0113r\u012bga alkohola lieto\u0161ana.<br \/>\n<strong>Ar z\u0101l\u0113m saist\u012bti riska faktori<\/strong><br \/>\n\u2022 NPL deva.<br \/>\n\u2022 Kombin\u0101cija ar citiem medikamentiem.<br \/>\n\u2022 Ilgsto\u0161a lieto\u0161ana (tr\u012bs m\u0113ne\u0161us un ilg\u0101k).<br \/>\nDa\u017e\u0101du NPL izrais\u012btais KZT komplik\u0101ciju risks at\u0161\u0137iras, tom\u0113r tas ir atkar\u012bgs ar\u012b no devas, lieto\u0161anas ilguma un pacienta individu\u0101lajiem riska faktoriem. Kopum\u0101 par zem\u0101ka KZT riska NPL tiek uzskat\u012bti <strong>celekoksibs, etorikoksibs, aceklofenaks, ibuprof\u0113ns<\/strong> un <strong>diklofenaks<\/strong>, savuk\u0101rt augst\u0101ks risks rakstur\u012bgs <strong>ketorolakam, piroksik\u0101mam, ketoprof\u0113nam<\/strong> un <strong>indometac\u012bnam. Meloksik\u0101ms<\/strong> un <strong>nimesul\u012bds<\/strong> parasti tiek saist\u012bti ar m\u0113ren\u0101ku KZT risku, ta\u010du ar\u012b to lieto\u0161anas laik\u0101 iesp\u0113jamas nopietnas KZT komplik\u0101cijas.<br \/>\n<strong>Ketorolaks<\/strong> ir \u012bpa\u0161i noz\u012bm\u012bgs riska zi\u0146\u0101 \u2013 t\u0101 lieto\u0161ana ir saist\u012bta ar paaugstin\u0101tu KZT asi\u0146o\u0161anas un \u010d\u016blu risku, \u012bpa\u0161i ilgas lieto\u0161anas gad\u012bjum\u0101. <strong>Piroksik\u0101mam<\/strong> ar\u012b ir sal\u012bdzino\u0161i augsts KZT komplik\u0101ciju risks.<\/p>\n<p><strong>Riska mazin\u0101\u0161anas iesp\u0113jas<\/strong><br \/>\n\u2022 Protonu s\u016bk\u0146a inhibitoru (PSI) lieto\u0161ana gastroprotekcijai pacientiem ar paaugstin\u0101tu KZT komplik\u0101ciju risku.<br \/>\n\u2022 Misoprostols (Latvij\u0101 nav re\u0123istr\u0113ts k\u0101 gastroprotekt\u012bvs l\u012bdzeklis).<br \/>\n\u2022 \u012aslaic\u012bga H\u2082 receptoru blokatoru lieto\u0161ana atsevi\u0161\u0137os gad\u012bjumos.<br \/>\n\u2022<em> H. pylori<\/em> infekcijas eradik\u0101cija.<br \/>\n\u2022 Ja kl\u012bniski iesp\u0113jams, priek\u0161roka dodama selekt\u012bviem COX-2 inhibitoriem pacientiem ar paaugstin\u0101tu KZT risku.<br \/>\nPeptisku \u010d\u016blu un KZT boj\u0101jumu risku, \u012bpa\u0161i kombin\u0101cij\u0101 ar NPL vai pacientiem ar jau eso\u0161iem riska faktoriem, var palielin\u0101t ar\u012b citi medikamenti, piem\u0113ram, <strong>bisfosfon\u0101ti, klopidogrels, kortiko\u012bdi, sirolims, spironolaktons, mikofenol\u0101ta mofetils, \u0137\u012bmijterapijas l\u012bdzek\u013ci<\/strong> u.c.<\/p>\n<p>\u00a0\n<\/p>\n<div style=\"width: 100%; max-width: 650px; height: 1011px; margin: 20px auto; overflow: hidden; position: relative;\"><iframe style=\"border: none; width: 900px; height: 1400px; position: absolute; top: 0; left: 0; transform: scale(0.7222); transform-origin: 0 0; max-width: none;\" src=\"\/wp-content\/uploads\/baneri\/2026-09-sandoz-esomeprazole\/\" scrolling=\"no\" title=\"Sandoz Esomeprazole\"><\/iframe><\/div>\n<h3>Slikta d\u016b\u0161a un vem\u0161ana<\/h3>\n<p>\nSlikta d\u016b\u0161a un vem\u0161ana var izrais\u012bt dehidrat\u0101ciju, nepietiekamu uzturvielu uz\u0146em\u0161anu, k\u0101 ar\u012b pastiprin\u0101t trauksmi un stresu pacientiem. \u0160os simptomus nevajadz\u0113tu ignor\u0113t, jo slikta d\u016b\u0161a un vem\u0161ana ir bie\u017e\u0101ko medikamentu p\u0101rdoz\u0113\u0161anas izpausmju vid\u016b. \u0160\u0101da reakcija ir \u013coti individu\u0101la un var b\u016bt atkar\u012bga no konkr\u0113t\u0101 medikamenta, t\u0101 devas un pacienta individu\u0101l\u0101m \u012bpatn\u012bb\u0101m.<br \/>\n<strong>Riska faktori<\/strong><br \/>\n\u2022 Lielas z\u0101\u013cu devas.<br \/>\n\u2022 \u012ass laiks kop\u0161 lieto\u0161anas s\u0101kuma.<br \/>\n\u2022 Medikamenta lieto\u0161ana \u0101rpus \u0113dienreiz\u0113m.<br \/>\n\u2022 Uztura re\u017e\u012bma neiev\u0113ro\u0161ana.<br \/>\n\u2022 Z\u0101\u013cu lieto\u0161ana noteikt\u0101 dienas laik\u0101 (piem\u0113ram, \u0161\u012bs blaknes mazin\u0101\u0161anai hormon\u0101l\u0101s kontracepcijas tabletes ieteicams lietot vakar\u0101).<br \/>\n<strong>Z\u0101\u013cu grupu un z\u0101\u013cu piem\u0113ri, kas var izrais\u012bt \u0161o blakni:<\/strong> NPL, digoks\u012bns, antiaritmiskie l\u012bdzek\u013ci, antihipertens\u012bvie l\u012bdzek\u013ci (\u03b2\u00a0blokatori, kalcija kan\u0101lu blokatori, diur\u0113tiskie l\u012bdzek\u013ci u.c.), dopam\u012bner\u0123iskie, pretinfekcijas, \u0137\u012bmijterapijas, kontracepcijas, pretepilepsijas l\u012bdzek\u013ci u.c.<br \/>\nJa pacients s\u016bdzas par \u0161iem simptomiem, st\u0101vok\u013ca v\u0113rt\u0113\u0161anai var izmantot algoritmu, kas redzams 1. att\u0113l\u0101.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter size-large wp-image-37622\" src=\"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/2026\/09\/ezof1-1024x395.jpg\" alt=\"\" width=\"618\" height=\"238\">\n<\/p>\n<h3>Aizciet\u0113jums<\/h3>\n<p>\n10\u201381% aizciet\u0113juma gad\u012bjumu var b\u016bt saist\u012bti ar z\u0101\u013cu lieto\u0161anu. Z\u0101\u013cu izrais\u012bts aizciet\u0113jums var rad\u012bt noz\u012bm\u012bgas ilgtermi\u0146a sekas, tostarp samazin\u0101t z\u0101\u013cu lieto\u0161anas l\u012bdzest\u012bbu un veicin\u0101t polifarm\u0101ciju t\u0101 d\u0113v\u0113t\u0101s z\u0101\u013cu kask\u0101des d\u0113\u013c, kad blakni \u0101rst\u0113 ar cit\u0101m z\u0101l\u0113m.<br \/>\nJ\u0101\u0146em v\u0113r\u0101, ka aizciet\u0113jums var b\u016bt ar\u012b da\u017e\u0101du slim\u012bbu un pacienta vesel\u012bbas st\u0101vok\u013ca izpausme. Pie noz\u012bm\u012bgiem riska faktoriem pieder funkcion\u0101la invalidit\u0101te, ilgsto\u0161a imobiliz\u0101cija, dz\u012bvo\u0161ana pansion\u0101t\u0101 vai ilgsto\u0161as apr\u016bpes iest\u0101d\u0113, endokr\u012bn\u0101s sist\u0113mas trauc\u0113jumi (cukura diab\u0113ts, hipotireoze, hiperparatireoze un panhipopituit\u0101risms), elektrol\u012btu l\u012bdzsvara trauc\u0113jumi (dehidrat\u0101cija, hipokali\u0113mija, hiponatr\u0113mija, hiperkalc\u0113mija un hipermagn\u0113mija), neirolo\u0123iski trauc\u0113jumi (Parkinsona slim\u012bba, demence, multipl\u0101 skleroze, neirop\u0101tija un muguras smadze\u0146u boj\u0101jumi), k\u0101 ar\u012b psihiski trauc\u0113jumi (depresija, anoreksija un \u0161izofr\u0113nija) u.c.<br \/>\nAizciet\u0113jums ir \u013coti bie\u017ea nev\u0113lama blakne pacientiem, kuri lieto opio\u012bdus \u2013 da\u017e\u0101dos p\u0113t\u012bjumos tas nov\u0113rots aptuveni 40\u201390% opio\u012bdu lietot\u0101ju.<br \/>\nOpio\u012bdi aizciet\u0113jumu izraisa galvenok\u0101rt, aktiv\u0113jot \u03bc opio\u012bdu receptorus zarn\u0101s, t\u0101d\u0113j\u0101di samazinot KZT motoriku un sekr\u0113ciju, k\u0101 ar\u012b palielinot an\u0101l\u0101 sfinktera tonusu.<br \/>\n<strong>Opio\u012bdu izrais\u012bta aizciet\u0113juma terapijas iesp\u0113jas<\/strong><br \/>\n\u2022 Pirms aizciet\u0113juma \u0101rst\u0113\u0161anas s\u0101k\u0161anas j\u0101v\u0113rt\u0113 opio\u012bdu lieto\u0161anas nepiecie\u0161am\u012bba un indik\u0101cijas, k\u0101 ar\u012b j\u0101nodro\u0161ina maz\u0101k\u0101 efekt\u012bv\u0101 opio\u012bda deva atbilsto\u0161i pacienta s\u0101pju kontrolei.<br \/>\n\u2022 Ja iesp\u0113jams, j\u0101apsver opio\u012bdu terapijas p\u0101rtrauk\u0161ana, devas samazin\u0101\u0161ana vai cita ievades veida izv\u0113le.<br \/>\n\u2022 Dz\u012bvesveida korekcija \u2013 pietiekama \u0161\u0137idruma uz\u0146em\u0161ana, fizisk\u0101s aktivit\u0101tes un, ja pacienta st\u0101voklis to pie\u013cauj, uztura \u0161\u0137iedrvielu daudzuma palielin\u0101\u0161ana.<br \/>\n\u2022 Laksat\u012bvu l\u012bdzek\u013cu lieto\u0161ana. Tie j\u0101lieto regul\u0101ri, nevis tikai p\u0113c nepiecie\u0161am\u012bbas. Aptuveni 75% pacientu uz \u0161\u0101du terapiju rea\u0123\u0113 pozit\u012bvi. Priek\u0161roka dodama polietil\u0113nglikolam (PEG). Laktuloze zarnu mikrobiotas ietekm\u0113 tiek ferment\u0113ta, kas var pastiprin\u0101t v\u0113dera uzp\u016b\u0161anos un meteorismu. Kairino\u0161ie laksat\u012bvie l\u012bdzek\u013ci lietojami piesardz\u012bgi.<br \/>\n\u2022 PAMORA (perif\u0113ri selekt\u012bvie \u03bc opio\u012bdu receptoru antagonisti) \u2013 medikamentu grupa, kas selekt\u012bvi blo\u0137\u0113 opio\u012bdu darb\u012bbu zarn\u0101s, b\u016btiski neietekm\u0113jot centr\u0101lo prets\u0101pju efektu.<br \/>\n\u2022 Zarnu sekr\u0113ciju veicino\u0161i l\u012bdzek\u013ci \u2013 terapijas iesp\u0113ja pacientiem, kuriem ar tradicion\u0101liem laksat\u012bviem l\u012bdzek\u013ciem nepietiekama efekta gad\u012bjum\u0101 j\u0101mekl\u0113 cita pieeja.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter size-large wp-image-37619\" src=\"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/2026\/09\/ezof2-779x1024.jpg\" alt=\"\" width=\"618\" height=\"812\">\n<\/p>\n<h3>Antihol\u012bner\u0123iskie l\u012bdzek\u013ci<\/h3>\n<p>\nAntihol\u012bner\u0123iskie l\u012bdzek\u013ci var izrais\u012bt aizciet\u0113jumu, nov\u0113r\u0161ot neirotransmitera acetilhol\u012bna saist\u012b\u0161anos ar muskar\u012bna M2 receptoriem zarn\u0101s, t\u0101d\u0113\u013c mazin\u0101s zarnu tonuss un kust\u012bgums.<br \/>\nApm\u0113ram 27% pacientu, kuri lieto antihol\u012bner\u0123iskos l\u012bdzek\u013cus, rodas aizciet\u0113jumi.<br \/>\nR\u012bc\u012bba: ieteicams samazin\u0101t devu vai apsv\u0113rt alternat\u012bvu terapiju.\n<\/p>\n<h3>Antidepresanti<\/h3>\n<p>\nAntihol\u012bner\u0123isk\u0101 un serotoner\u0123isk\u0101 darb\u012bba mazina zarnu kust\u012bgumu un sekr\u0113ciju.<br \/>\nR\u012bc\u012bba: nepiecie\u0161am\u012bbas gad\u012bjum\u0101 apsv\u0113rt p\u0101reju uz citu antidepresantu; var lietot \u0161\u0137iedrvielas, osmotiskos vai stimul\u0113jo\u0161os caurejas l\u012bdzek\u013cus.\n<\/p>\n<h3>Antipsihotiskie l\u012bdzek\u013ci<\/h3>\n<p>\nAntihol\u012bner\u0123isk\u0101, dopam\u012bner\u0123isk\u0101 un histam\u012bner\u0123isk\u0101 aktivit\u0101te var v\u0101jin\u0101t zarnu kust\u012bgumu. Klozap\u012bns var izteikti kav\u0113t zarnu tranz\u012btu.<br \/>\nR\u012bc\u012bba: klozap\u012bna lieto\u0161anas gad\u012bjum\u0101 apsv\u0113rt profilaktisku caurejas l\u012bdzek\u013cu lieto\u0161anu un r\u016bp\u012bgi uzraudz\u012bt zarnu darb\u012bbu. Devu palielin\u0101\u0161ana j\u0101veic pak\u0101peniski; var lietot PEG vai stimul\u0113jo\u0161os caurejas l\u012bdzek\u013cus.\n<\/p>\n<h3>Kalcija kan\u0101lu blokatori<\/h3>\n<p>\nVerapamils un diltiazems var izrais\u012bt aizciet\u0113jumu; tas nov\u0113rots aptuveni 7% pacientu.<br \/>\nTas galvenok\u0101rt saist\u012bts ar KZT gludo musku\u013cu kontrakciju inhib\u012bciju, blo\u0137\u0113jot L tipa kalcija kan\u0101lus, kuriem ir noz\u012bme zarnu peristaltik\u0101.<br \/>\nTerapijas iesp\u0113jas:<br \/>\n\u2022 palielin\u0101t \u0161\u0137iedrvielu un \u0161\u0137idruma uz\u0146em\u0161anu un veicin\u0101t regul\u0101ras fizisk\u0101s aktivit\u0101tes, lai stimul\u0113tu zarnu kust\u012bgumu;<br \/>\n\u2022 ja simptomi saglab\u0101jas, lietot osmotiskos caurejas l\u012bdzek\u013cus (piem\u0113ram, PEG) vai stimul\u0113jo\u0161os caurejas l\u012bdzek\u013cus;<br \/>\n\u2022 rezistentos gad\u012bjumos apsv\u0113rt p\u0101reju uz citu kalcija kan\u0101lu blokatoru ar maz\u0101ku ietekmi uz KZT, piem\u0113ram, amlodip\u012bnu, ja tas ir sader\u012bgs ar pacienta kardiovaskul\u0101ro terapiju;<br \/>\n\u2022 ja p\u0101reja uz citu kalcija kan\u0101lu blokatoru nav iesp\u0113jama, var apsv\u0113rt p\u0101reju uz ilgsto\u0161as darb\u012bbas z\u0101\u013cu formu. Tas var samazin\u0101t simptomu intensit\u0101ti, bet neietekm\u0113 aizciet\u0113juma sastopam\u012bbu.\n<\/p>\n<h3>Peror\u0101lie dzelzs prepar\u0101ti<\/h3>\n<p>\nDzelzs zarn\u0101s var veicin\u0101t reakt\u012bvo sk\u0101bek\u013ca savienojumu veido\u0161anos, izraisot g\u013cot\u0101das iekaisumu, oksidat\u012bvo stresu un zarnu barjerfunkcijas trauc\u0113jumus. Turkl\u0101t dzelzs var main\u012bt zarnu mikrobiotu, samazinot labv\u0113l\u012bgo bakt\u0113riju daudzumu un vairojot iekaisumu veicino\u0161as sugas, kas var mazin\u0101t KZT kust\u012bgumu.<br \/>\nDzelzs izrais\u012bts aizciet\u0113jums var b\u016bt \u012bpa\u0161i problem\u0101tisks pacientiem, kuri lieto dzelzs sulf\u0101tu, kas \u0101tri atbr\u012bvo br\u012bvos dzelzs jonus.<br \/>\nLai mazin\u0101tu simptomus:<br \/>\n\u2022 var apsv\u0113rt p\u0101reju uz alternat\u012bvu dzelzs prepar\u0101tu vai z\u0101\u013cu formu, piem\u0113ram, dzelzs citr\u0101tu, l\u0113nas darb\u012bbas dzelzs prepar\u0101tu, h\u0113ma dzelzs vai hel\u0101tu prepar\u0101tu;<br \/>\n\u2022 var pal\u012bdz\u0113t devas sadal\u012b\u0161ana;<br \/>\n\u2022 dzelzs lieto\u0161ana kop\u0101 ar \u0113dienu var mazin\u0101t KZT blaknes, bet \u0113diens var samazin\u0101t dzelzs uzs\u016bk\u0161anos;<br \/>\n\u2022 noz\u012bm\u012bgas nepanes\u012bbas gad\u012bjum\u0101 izmanto intravenozu dzelzs ievad\u012b\u0161anu.\n<\/p>\n<h3>Diur\u0113tiskie l\u012bdzek\u013ci<\/h3>\n<p>\n\u012apa\u0161i tiaz\u012bdu un cilpas diur\u0113tiskie l\u012bdzek\u013ci var veicin\u0101t aizciet\u0113jumu, izraisot \u0161\u0137idruma un elektrol\u012btu l\u012bdzsvara trauc\u0113jumus. \u0160\u012bs z\u0101les palielina \u016bdens un elektrol\u012btu, \u012bpa\u0161i n\u0101trija un k\u0101lija, izdal\u012b\u0161anos ar ur\u012bnu, kas var izrais\u012bt dehidrat\u0101ciju un samazin\u0101t \u016bdens saturu resnaj\u0101 zarn\u0101.<br \/>\nHipokali\u0113mija, kas var rasties cilpas un tiaz\u012bdu diur\u0113tisko l\u012bdzek\u013cu lieto\u0161anas laik\u0101, var pasliktin\u0101t zarnu glud\u0101s muskulat\u016bras darb\u012bbu, samazin\u0101t peristaltiku un pal\u0113nin\u0101t zarnu tranz\u012btu.<br \/>\nAizciet\u0113jums nav rakstur\u012bga diur\u0113tisko l\u012bdzek\u013cu blakne, bet tas var rasties riska grupas pacientiem, \u012bpa\u0161i gados vec\u0101kiem cilv\u0113kiem, pacientiem ar nepietiekamu \u0161\u0137idruma uz\u0146em\u0161anu vai pacientiem, kuri lieto lielas devas vai kombin\u0113tu diur\u0113tisko terapiju.<br \/>\n\u0100rst\u0113\u0161ana: j\u0101veicina pietiekama \u0161\u0137idruma uz\u0146em\u0161ana, ja vien t\u0101 nav medic\u012bniski kontrindic\u0113ta, k\u0101 ar\u012b j\u0101kori\u0123\u0113 elektrol\u012btu, \u012bpa\u0161i k\u0101lija, l\u012bdzsvara trauc\u0113jumi.<br \/>\nSimptom\u0101tiskai \u0101rst\u0113\u0161anai var izmantot standarta aizciet\u0113juma \u0101rst\u0113\u0161anas metodes, piem\u0113ram, \u0161\u0137iedrvielas, osmotiskos vai stimul\u0113jo\u0161os caurejas l\u012bdzek\u013cus.<br \/>\nCiti medikamenti, kas var izrais\u012bt aizciet\u0113jumu<br \/>\n\u2022 Alum\u012bnija antac\u012bdi l\u012bdzek\u013ci<br \/>\n\u2022 Ilgsto\u0161i lietoti caurejas l\u012bdzek\u013ci<br \/>\n\u2022 Ondansetrons<br \/>\n\u2022 Levotiroks\u012bns<br \/>\n\u2022 \u0136\u012bmijterapijas l\u012bdzek\u013ci<br \/>\n\u2022 Musku\u013cu relaksanti<br \/>\n\u2022 Fenobarbit\u0101ls<br \/>\n\u2022 NPL u.c.\n<\/p>\n<h3>Caureja<\/h3>\n<p>\nZ\u0101\u013cu izrais\u012bta caureja bie\u017ei rodas dr\u012bz p\u0113c medikamenta lieto\u0161anas s\u0101k\u0161anas. Vair\u0101k nek\u0101 700 medikamentu ir atz\u012bti par iesp\u0113jamiem caurejas izrais\u012bt\u0101jiem.<br \/>\nZ\u0101\u013cu lieto\u0161ana var b\u016bt saist\u012bta ar\u012b ar hroniskas caurejas att\u012bst\u012bbu.<\/p>\n<p><strong>Antibiotiku izrais\u012bta caureja (25\u201330% pacientu)<\/strong><\/p>\n<p>Antibiotiku izrais\u012bta caureja p\u0101rsvar\u0101 ir saist\u012bta ar zarnu mikrofloras izmai\u0146\u0101m. Nopietn\u0101ka komplik\u0101cija ir Clostridioides difficile (C. difficile) infekcija, kas izraisa aptuveni 15\u201325% antibiotiku izrais\u012btas caurejas gad\u012bjumu.<br \/>\nSimptomi var s\u0101kties antibiotikterapijas laik\u0101 vai p\u0113c t\u0101s, un vairum\u0101 gad\u012bjumu tie rodas 2 ned\u0113\u013cu laik\u0101 p\u0113c antibiotikterapijas. Retos gad\u012bjumos simptomi var rasties pat 10 ned\u0113\u013cas p\u0113c antibiotikterapijas p\u0101rtrauk\u0161anas. Papildu riska faktori ir vecums virs 65 gadiem, nesena hospitaliz\u0101cija un protonu s\u016bk\u0146a inhibitoru lieto\u0161ana.<br \/>\nRakstur\u012bga \u016bde\u0146aina caureja (\u22653 \u0161\u0137idras v\u0113dera izejas 24 stundu laik\u0101). Citas izpausmes ir s\u0101pes v\u0113dera lejasda\u013c\u0101 un krampji, drudzis (aptuveni 15% gad\u012bjumu), slikta d\u016b\u0161a un \u0113stgribas zudums. Caureja var b\u016bt ar g\u013cot\u0101m vai sl\u0113pt\u0101m asin\u012bm, savuk\u0101rt mel\u0113na vai hematoh\u0113zija ir reti.<br \/>\nL\u012bdz 25% pacientu C. difficile infekcija atk\u0101rtojas 30 dienu laik\u0101 p\u0113c \u0101rst\u0113\u0161anas pabeig\u0161anas.<br \/>\nC. difficile infekcijas risks ir \u012bpa\u0161i saist\u012bts ar pla\u0161a spektra antibiotiku lieto\u0161anu, tostarp penicil\u012bniem, cefalospor\u012bniem, fluorhinoloniem, klindamic\u012bnu u.c.<br \/>\nZ\u0101les, kas var izrais\u012bt caureju, var b\u016bt prokin\u0113tiski l\u012bdzek\u013ci, magniju saturo\u0161i prepar\u0101ti, dzelzs prepar\u0101ti, antidepresanti, metform\u012bns, C vitam\u012bns (\u012bpa\u0161i liel\u0101s dev\u0101s), \u0137\u012bmijterapijas l\u012bdzek\u013ci, antihipertens\u012bvi l\u012bdzek\u013ci (AKE inhibitori, angiotens\u012bna II receptoru blokatori, b\u0113ta adrenoblokatori), sulfasalaz\u012bns, NPL, PSI, stat\u012bni, karbamazep\u012bns u.c.<\/p>\n<p><strong>Terapijas iesp\u0113jas<\/strong><br \/>\nZ\u0101\u013cu izrais\u012btas caurejas gad\u012bjum\u0101 \u0101rst\u0113\u0161anas taktika ir atkar\u012bga no simptomu smaguma un c\u0113lo\u0146a. Iesp\u0113jamie risin\u0101jumi ir:<br \/>\n\u2022 z\u0101\u013cu atcel\u0161ana un alternat\u012bvas terapijas izv\u0113rt\u0113\u0161ana;<br \/>\n\u2022 cita ra\u017eot\u0101ja z\u0101\u013cu izv\u0113le, ja ir aizdomas, ka blakni var\u0113tu izrais\u012bt k\u0101da pal\u012bgviela;<br \/>\n\u2022 nogaid\u012b\u0161ana, jo da\u017eos gad\u012bjumos caureja ar laiku var spont\u0101ni mazin\u0101ties;<br \/>\n\u2022 devas samazin\u0101\u0161ana, ja tas ir kl\u012bniski iesp\u0113jams;<br \/>\n\u2022 prepar\u0101ta lieto\u0161ana p\u0113c \u0113\u0161anas, ja to pie\u013cauj z\u0101\u013cu lieto\u0161anas instrukcija;<br \/>\n\u2022 z\u0101\u013cu formas, s\u0101ls vai akt\u012bv\u0101s vielas mai\u0146a;<br \/>\n\u2022 atbilsto\u0161as di\u0113tas iev\u0113ro\u0161ana;<br \/>\n\u2022 citu vienlaikus lietotu medikamentu vai uztura bag\u0101tin\u0101t\u0101ju izv\u0113rt\u0113\u0161ana, kas var\u0113tu pastiprin\u0101t simptomus.<br \/>\nPersist\u0113jo\u0161as caurejas gad\u012bjum\u0101 nepiecie\u0161ama rehidrat\u0101cija, lai kompens\u0113tu \u0161\u0137idruma un elektrol\u012btu zudumu. Atsevi\u0161\u0137os gad\u012bjumos var izmantot pretcaurejas l\u012bdzek\u013cus, piem\u0113ram, loperam\u012bdu, k\u0101 ar\u012b adsorbentus.<br \/>\nJ\u0101\u0146em v\u0113r\u0101, ka adsorb\u0113jo\u0161i prepar\u0101ti var kav\u0113t citu z\u0101\u013cu uzs\u016bk\u0161anos un\/vai samazin\u0101t uzs\u016bku\u0161os z\u0101\u013cu daudzumu. T\u0101d\u0113\u013c tos nav ieteicams lietot vienlaikus ar cit\u0101m z\u0101l\u0113m; parasti ieteicams iev\u0113rot vismaz 2 stundu interv\u0101lu starp adsorbenta un citu z\u0101\u013cu lieto\u0161anu.<\/p>\n<p><strong>2. tabula.<\/strong> Z\u0101\u013cu izrais\u012btas caurejas profilakse un \u0101rst\u0113\u0161ana\n<\/p>\n<p><strong>Profilakse <\/strong><strong>Terapija<\/strong>Iesp\u0113jams, j\u0101apsver probiotiku lieto\u0161ana, jo p\u0113t\u012bjumos konstat\u0113ta caurejas riska samazin\u0101\u0161an\u0101s par aptuveni 18\u201320%.<br \/>\nBie\u017e\u0101k ieteikt\u0101s probiotikas ir Saccharomyces boulardii, Lactobacillus acidophilus CL1285, Lactobacillus casei u.c.C. difficile infekcijas gad\u012bjum\u0101 tiek lietota efekt\u012bva antibakteri\u0101la terapija, piem\u0113ram, vankomic\u012bns vai metronidazols.<strong>Al\u012bna Krivi\u0146a,<\/strong><\/p>\n<p> Paula Stradi\u0146a kl\u012bnisk\u0101s universit\u0101tes slimn\u012bcas kl\u012bnisk\u0101 farmaceite, RSU Farmakolo\u0123ijas un farmakoterapijas katedras doc\u0113t\u0101ja, SIA \u201cLatvijas aptieka\u201d farmaceite<\/p>\n<p><strong>V\u0113res<\/strong><br \/>\n<em>1. Darren C.R., Fernandes et al. Drug-induced gastrointestinal disorders. Medicine, 2019 May, 47 (5): 301-308.<\/em><br \/>\n<em>2. Domagala-Rodacka R. Gastrointestinal tract as a side-effect target of medications. 2016.<\/em><br \/>\n<em>3. Philpott H. L. et al. Drug-induced gastrointestinal disorders. Frontline Gastroenterol. 2013 Jun 19; 5 (1): 49\u201357.<\/em><br \/>\n<em>4. Melissa J. et al. Imaging of drug-induced complications in the gastrointestinal system. RadioGraphics, 2016.<\/em><br \/>\n<em>5. Peptic ulcer disease: Epidemiology, etiology, and pathogenesis. Uptodate, sk. 8.06.2026.<\/em><br \/>\n<em>6. NSAIDs (including aspirin): Pathogenesis and risk factors for gastroduodenal toxicity. Uptodate, sk. 8.06.2026.<\/em><br \/>\n<em>7. Pill esophagitis. Uptodate, sk. 8.06.2026.<\/em><br \/>\n<em>8. Patient education: Dry mouth (The Basics). Uptodate, sk. 8.06.2026.<\/em><br \/>\n<em>9. Treister N. S. et. Chemotherapy-induced oral mucositis. 2023.<\/em><br \/>\n<em>10. Matsuo H. et al. Fact-finding survey and exploration of preventive drugs for antineoplastic drug-induced oral mucositis using the Japanese dverse Drug Event Report Database, Sci. Pharm. 2024, 92 (2), 34.<\/em><br \/>\n<em>11. Jinbu Y. et al. Oral ulcerations due to drug medications. Japanese Dental Science Review, May 2014, 50 (2).<\/em><br \/>\n<em>12. Clostridioides difficile infection in adults: Clinical manifestations and diagnosis. Uptodate, sk. 8.06.2026.<\/em><br \/>\n<em>13. Yu Aung T. et al. Drugs induced nausea and vomiting: an overview. IOSR Journal of Pharmacy and Biological Sciences, 2016.<\/em><br \/>\n<em>14. Norman A. J. et al. Drug-induced gastrointestinal disorders. Elsevier Ltd, 2023.<\/em><br \/>\n<em>15. Chakraborty H., Drug-induced gastrointestinal disorders: A comprehensive review. Acta Scientific Gastrointestinal Disorders 7.9. 2024: 24-28.<\/em><br \/>\n<em>16. Abraham B. P. et al. Drug-induced, factitious, idiopathic diarrhea. Best Practice &amp; Research Clinical Gastroenterology, 2012.<\/em><br \/>\n<em>17. Philip N. A., Pitchumoni C. S. Spectrum of drug-induced chronic diarrhea. J Clin Gastroenterol., 2017; 51: 111\u2013117.<\/em><br \/>\n<em>18. Gotfried J. Drug-related gastroenteritis and chemical-related gastroenteritis, 2025.<\/em><br \/>\n<em>19. LeWine H. E. Antibiotic-associated diarrhoea, 2023.<\/em><br \/>\n<em>20. Approach to the adult with chronic diarrhea in resource-abundant settings. Uptodate, sk. 10.02.2026.<\/em><br \/>\n<em>21. Overview of the causes of chronic diarrhea in children in resource-abundant settings. Uptodate, sk. 10.02.2026.<\/em><br \/>\n<em>22. Acute diarrhea in adults. Dynamed, sk. 10.02.2026.<\/em><br \/>\n<em>23. Chronic diarrhea in adults. Uptodate, sk. 10.02.2026.<\/em><br \/>\n<em>24. Johnson D. A. et al. A pharmacy of suspects: drug-induced diarrhea\u2019s likeliest causes. Medscape, 2017.<\/em><br \/>\n<em>25. Gregorian T. et al. Opioid-induced constipation: clinical guidance and approved therapies. US Pharm., 2017; 42 (12) 15\u201319.<\/em><br \/>\n<em>26. Giara K. Which drugs commonly cause constipation? 2026.<\/em><br \/>\n<em>27. Squeo F. et al. Opioid-induced constipation: old and new concepts in diagnosis and treatment. J. Neurogastroenterol Motil., 2024; 30 (2): 131\u2013142.<\/em><\/p>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Aptuveni 40% z\u0101\u013cu nev\u0113lamo blak\u0146u skar gremo\u0161anas traktu. J\u0101\u0146em v\u0113r\u0101, ka gremo\u0161anas trakta darb\u012bbas trauc\u0113jumus var izrais\u012bt ne tikai peror\u0101li lietojamas z\u0101les, bet ar\u012b medikamenti, kas ievad\u012bti cit\u0101 veid\u0101. Iesp\u0113jamie [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"mic_cinema_image":0,"mic_focus":"","mic_cinema_focus":"","footnotes":"","_labiux_rail":0},"categories":[70,76,73,191],"tags":[2946,2947,2948],"mic_flag":[64],"class_list":["post-22902","post","type-post","status-publish","format-standard","hentry","category-farmacijas-zinas","category-jaunakie-raksti","category-medikamentu-zinas","category-reklamraksts","tag-esomeprazole","tag-esomeprazols","tag-kunga-cula","mic_flag-reklamraksts"],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO 5.0.4 - aioseo.com -->\n\t<meta name=\"description\" content=\"Aptuveni 40% z\u0101\u013cu nev\u0113lamo blak\u0146u skar gremo\u0161anas traktu. J\u0101\u0146em v\u0113r\u0101, ka gremo\u0161anas trakta darb\u012bbas trauc\u0113jumus var izrais\u012bt ne tikai peror\u0101li lietojamas z\u0101les, bet ar\u012b medikamenti, kas ievad\u012bti cit\u0101 veid\u0101. Iesp\u0113jamie meh\u0101nismi: \u2022 paredzama z\u0101\u013cu farmakolo\u0123isk\u0101s darb\u012bbas izpausme; \u2022 tie\u0161s g\u013cot\u0101das vai audu boj\u0101jums; \u2022 zarnu mikrobiotas izmai\u0146as; \u2022 iedarb\u012bba \u0101rpus gremo\u0161anas trakta ar sekund\u0101ru ietekmi\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<meta name=\"author\" content=\"admin\"\/>\n\t<link rel=\"canonical\" href=\"https:\/\/farmacija-mic.lv\/en\/zalu-nelabveliga-ietekme-uz-gremosanas-traktu-un-palidzibas-iespejas\/\" \/>\n\t\t<meta name=\"generator\" content=\"All in One SEO (AIOSEO) 5.0.4\" \/>\n\t\t<meta property=\"og:locale\" content=\"en_US\" \/>\n\t\t<meta property=\"og:site_name\" content=\"Medikamentu Inform\u0101cijas Centrs\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"Z\u0101\u013cu nelabv\u0113l\u012bga ietekme uz gremo\u0161anas traktu un pal\u012bdz\u012bbas iesp\u0113jas - Medikamentu Inform\u0101cijas Centrs\" \/>\n\t\t<meta property=\"og:description\" content=\"Aptuveni 40% z\u0101\u013cu nev\u0113lamo blak\u0146u skar gremo\u0161anas traktu. J\u0101\u0146em v\u0113r\u0101, ka gremo\u0161anas trakta darb\u012bbas trauc\u0113jumus var izrais\u012bt ne tikai peror\u0101li lietojamas z\u0101les, bet ar\u012b medikamenti, kas ievad\u012bti cit\u0101 veid\u0101. Iesp\u0113jamie meh\u0101nismi: \u2022 paredzama z\u0101\u013cu farmakolo\u0123isk\u0101s darb\u012bbas izpausme; \u2022 tie\u0161s g\u013cot\u0101das vai audu boj\u0101jums; \u2022 zarnu mikrobiotas izmai\u0146as; \u2022 iedarb\u012bba \u0101rpus gremo\u0161anas trakta ar sekund\u0101ru ietekmi\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/farmacija-mic.lv\/en\/zalu-nelabveliga-ietekme-uz-gremosanas-traktu-un-palidzibas-iespejas\/\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2026-09-15T09:58:21+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2026-10-16T19:27:53+00:00\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n\t\t<meta name=\"twitter:title\" content=\"Z\u0101\u013cu nelabv\u0113l\u012bga ietekme uz gremo\u0161anas traktu un pal\u012bdz\u012bbas iesp\u0113jas - Medikamentu Inform\u0101cijas Centrs\" \/>\n\t\t<meta name=\"twitter:description\" content=\"Aptuveni 40% z\u0101\u013cu nev\u0113lamo blak\u0146u skar gremo\u0161anas traktu. J\u0101\u0146em v\u0113r\u0101, ka gremo\u0161anas trakta darb\u012bbas trauc\u0113jumus var izrais\u012bt ne tikai peror\u0101li lietojamas z\u0101les, bet ar\u012b medikamenti, kas ievad\u012bti cit\u0101 veid\u0101. Iesp\u0113jamie meh\u0101nismi: \u2022 paredzama z\u0101\u013cu farmakolo\u0123isk\u0101s darb\u012bbas izpausme; \u2022 tie\u0161s g\u013cot\u0101das vai audu boj\u0101jums; \u2022 zarnu mikrobiotas izmai\u0146as; \u2022 iedarb\u012bba \u0101rpus gremo\u0161anas trakta ar sekund\u0101ru ietekmi\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/zalu-nelabveliga-ietekme-uz-gremosanas-traktu-un-palidzibas-iespejas\\\/#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#listItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/category\\\/farmacijas-zinas\\\/#listItem\",\"name\":\"Farm\\u0101cija\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/category\\\/farmacijas-zinas\\\/#listItem\",\"position\":2,\"name\":\"Farm\\u0101cija\",\"item\":\"https:\\\/\\\/farmacija-mic.lv\\\/category\\\/farmacijas-zinas\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/zalu-nelabveliga-ietekme-uz-gremosanas-traktu-un-palidzibas-iespejas\\\/#listItem\",\"name\":\"Z\\u0101\\u013cu nelabv\\u0113l\\u012bga ietekme uz gremo\\u0161anas traktu  un pal\\u012bdz\\u012bbas iesp\\u0113jas\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#listItem\",\"name\":\"Home\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/zalu-nelabveliga-ietekme-uz-gremosanas-traktu-un-palidzibas-iespejas\\\/#listItem\",\"position\":3,\"name\":\"Z\\u0101\\u013cu nelabv\\u0113l\\u012bga ietekme uz gremo\\u0161anas traktu  un pal\\u012bdz\\u012bbas iesp\\u0113jas\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/category\\\/farmacijas-zinas\\\/#listItem\",\"name\":\"Farm\\u0101cija\"}}]},{\"@type\":\"NewsArticle\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/zalu-nelabveliga-ietekme-uz-gremosanas-traktu-un-palidzibas-iespejas\\\/#newsarticle\",\"name\":\"Z\\u0101\\u013cu nelabv\\u0113l\\u012bga ietekme uz gremo\\u0161anas traktu un pal\\u012bdz\\u012bbas iesp\\u0113jas - Medikamentu Inform\\u0101cijas Centrs\",\"headline\":\"Z\\u0101\\u013cu nelabv\\u0113l\\u012bga ietekme uz gremo\\u0161anas traktu  un pal\\u012bdz\\u012bbas iesp\\u0113jas\",\"author\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/author\\\/admin\\\/#author\"},\"publisher\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#organization\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/farmacija-mic.lv\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/ezof1.jpg\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/zalu-nelabveliga-ietekme-uz-gremosanas-traktu-un-palidzibas-iespejas\\\/#articleImage\",\"width\":1478,\"height\":570},\"datePublished\":\"2026-09-15T11:58:21+03:00\",\"dateModified\":\"2026-10-16T22:27:53+03:00\",\"inLanguage\":\"en-US\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/zalu-nelabveliga-ietekme-uz-gremosanas-traktu-un-palidzibas-iespejas\\\/#webpage\"},\"isPartOf\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/zalu-nelabveliga-ietekme-uz-gremosanas-traktu-un-palidzibas-iespejas\\\/#webpage\"},\"articleSection\":\"Farm\\u0101cija, Jaun\\u0101kie raksti, Medikamenti, Rekl\\u0101mraksts, esomeprazole, esomeprazols, ku\\u0146\\u0123a \\u010d\\u016bla, Rekl\\u0101mraksts\",\"dateline\":\"Published on September 15, 2026.\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#organization\",\"name\":\"Medikamentu Inform\\u0101cijas Centrs\",\"description\":\"Farm\\u0101cijas nozares port\\u0101ls farmaceitiem un \\u0101rstiem. Zi\\u0146as, normat\\u012bvie akti, pas\\u0101kumi un t\\u0101l\\u0101kizgl\\u012bt\\u012bba vienuviet kop\\u0161 2001. gada.\",\"url\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/author\\\/admin\\\/#author\",\"url\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/author\\\/admin\\\/\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/zalu-nelabveliga-ietekme-uz-gremosanas-traktu-un-palidzibas-iespejas\\\/#authorImage\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/be3221a6fac131657111728b4d912a877ec158b123d5db3afef3bd8a59784ece?s=96&d=mm&r=g\",\"width\":96,\"height\":96,\"caption\":\"admin\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/zalu-nelabveliga-ietekme-uz-gremosanas-traktu-un-palidzibas-iespejas\\\/#webpage\",\"url\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/zalu-nelabveliga-ietekme-uz-gremosanas-traktu-un-palidzibas-iespejas\\\/\",\"name\":\"Z\\u0101\\u013cu nelabv\\u0113l\\u012bga ietekme uz gremo\\u0161anas traktu un pal\\u012bdz\\u012bbas iesp\\u0113jas - Medikamentu Inform\\u0101cijas Centrs\",\"description\":\"Aptuveni 40% z\\u0101\\u013cu nev\\u0113lamo blak\\u0146u skar gremo\\u0161anas traktu. J\\u0101\\u0146em v\\u0113r\\u0101, ka gremo\\u0161anas trakta darb\\u012bbas trauc\\u0113jumus var izrais\\u012bt ne tikai peror\\u0101li lietojamas z\\u0101les, bet ar\\u012b medikamenti, kas ievad\\u012bti cit\\u0101 veid\\u0101. Iesp\\u0113jamie meh\\u0101nismi: \\u2022 paredzama z\\u0101\\u013cu farmakolo\\u0123isk\\u0101s darb\\u012bbas izpausme; \\u2022 tie\\u0161s g\\u013cot\\u0101das vai audu boj\\u0101jums; \\u2022 zarnu mikrobiotas izmai\\u0146as; \\u2022 iedarb\\u012bba \\u0101rpus gremo\\u0161anas trakta ar sekund\\u0101ru ietekmi\",\"inLanguage\":\"en-US\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/zalu-nelabveliga-ietekme-uz-gremosanas-traktu-un-palidzibas-iespejas\\\/#breadcrumblist\"},\"author\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/author\\\/admin\\\/#author\"},\"creator\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/author\\\/admin\\\/#author\"},\"datePublished\":\"2026-09-15T11:58:21+03:00\",\"dateModified\":\"2026-10-16T22:27:53+03:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/\",\"name\":\"Medikamentu Inform\\u0101cijas Centrs\",\"description\":\"Farm\\u0101cijas nozares port\\u0101ls farmaceitiem un \\u0101rstiem. Zi\\u0146as, normat\\u012bvie akti, pas\\u0101kumi un t\\u0101l\\u0101kizgl\\u012bt\\u012bba vienuviet kop\\u0161 2001. gada.\",\"inLanguage\":\"en-US\",\"publisher\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO -->\n\n","aioseo_head_json":{"title":"Z\u0101\u013cu nelabv\u0113l\u012bga ietekme uz gremo\u0161anas traktu un pal\u012bdz\u012bbas iesp\u0113jas - Medikamentu Inform\u0101cijas Centrs","description":"Aptuveni 40% z\u0101\u013cu nev\u0113lamo blak\u0146u skar gremo\u0161anas traktu. J\u0101\u0146em v\u0113r\u0101, ka gremo\u0161anas trakta darb\u012bbas trauc\u0113jumus var izrais\u012bt ne tikai peror\u0101li lietojamas z\u0101les, bet ar\u012b medikamenti, kas ievad\u012bti cit\u0101 veid\u0101. Iesp\u0113jamie meh\u0101nismi: \u2022 paredzama z\u0101\u013cu farmakolo\u0123isk\u0101s darb\u012bbas izpausme; \u2022 tie\u0161s g\u013cot\u0101das vai audu boj\u0101jums; \u2022 zarnu mikrobiotas izmai\u0146as; \u2022 iedarb\u012bba \u0101rpus gremo\u0161anas trakta ar sekund\u0101ru ietekmi","canonical_url":"https:\/\/farmacija-mic.lv\/en\/zalu-nelabveliga-ietekme-uz-gremosanas-traktu-un-palidzibas-iespejas\/","robots":"max-image-preview:large","keywords":"","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BreadcrumbList","@id":"https:\/\/farmacija-mic.lv\/en\/zalu-nelabveliga-ietekme-uz-gremosanas-traktu-un-palidzibas-iespejas\/#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/en\/#listItem","position":1,"name":"Home","item":"https:\/\/farmacija-mic.lv\/en\/","nextItem":{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/category\/farmacijas-zinas\/#listItem","name":"Farm\u0101cija"}},{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/category\/farmacijas-zinas\/#listItem","position":2,"name":"Farm\u0101cija","item":"https:\/\/farmacija-mic.lv\/category\/farmacijas-zinas\/","nextItem":{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/en\/zalu-nelabveliga-ietekme-uz-gremosanas-traktu-un-palidzibas-iespejas\/#listItem","name":"Z\u0101\u013cu nelabv\u0113l\u012bga ietekme uz gremo\u0161anas traktu  un pal\u012bdz\u012bbas iesp\u0113jas"},"previousItem":{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/en\/#listItem","name":"Home"}},{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/en\/zalu-nelabveliga-ietekme-uz-gremosanas-traktu-un-palidzibas-iespejas\/#listItem","position":3,"name":"Z\u0101\u013cu nelabv\u0113l\u012bga ietekme uz gremo\u0161anas traktu  un pal\u012bdz\u012bbas iesp\u0113jas","previousItem":{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/category\/farmacijas-zinas\/#listItem","name":"Farm\u0101cija"}}]},{"@type":"NewsArticle","@id":"https:\/\/farmacija-mic.lv\/en\/zalu-nelabveliga-ietekme-uz-gremosanas-traktu-un-palidzibas-iespejas\/#newsarticle","name":"Z\u0101\u013cu nelabv\u0113l\u012bga ietekme uz gremo\u0161anas traktu un pal\u012bdz\u012bbas iesp\u0113jas - Medikamentu Inform\u0101cijas Centrs","headline":"Z\u0101\u013cu nelabv\u0113l\u012bga ietekme uz gremo\u0161anas traktu  un pal\u012bdz\u012bbas iesp\u0113jas","author":{"@id":"https:\/\/farmacija-mic.lv\/en\/author\/admin\/#author"},"publisher":{"@id":"https:\/\/farmacija-mic.lv\/en\/#organization"},"image":{"@type":"ImageObject","url":"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/2026\/09\/ezof1.jpg","@id":"https:\/\/farmacija-mic.lv\/en\/zalu-nelabveliga-ietekme-uz-gremosanas-traktu-un-palidzibas-iespejas\/#articleImage","width":1478,"height":570},"datePublished":"2026-09-15T11:58:21+03:00","dateModified":"2026-10-16T22:27:53+03:00","inLanguage":"en-US","mainEntityOfPage":{"@id":"https:\/\/farmacija-mic.lv\/en\/zalu-nelabveliga-ietekme-uz-gremosanas-traktu-un-palidzibas-iespejas\/#webpage"},"isPartOf":{"@id":"https:\/\/farmacija-mic.lv\/en\/zalu-nelabveliga-ietekme-uz-gremosanas-traktu-un-palidzibas-iespejas\/#webpage"},"articleSection":"Farm\u0101cija, Jaun\u0101kie raksti, Medikamenti, Rekl\u0101mraksts, esomeprazole, esomeprazols, ku\u0146\u0123a \u010d\u016bla, Rekl\u0101mraksts","dateline":"Published on September 15, 2026."},{"@type":"Organization","@id":"https:\/\/farmacija-mic.lv\/en\/#organization","name":"Medikamentu Inform\u0101cijas Centrs","description":"Farm\u0101cijas nozares port\u0101ls farmaceitiem un \u0101rstiem. Zi\u0146as, normat\u012bvie akti, pas\u0101kumi un t\u0101l\u0101kizgl\u012bt\u012bba vienuviet kop\u0161 2001. gada.","url":"https:\/\/farmacija-mic.lv\/en\/"},{"@type":"Person","@id":"https:\/\/farmacija-mic.lv\/en\/author\/admin\/#author","url":"https:\/\/farmacija-mic.lv\/en\/author\/admin\/","name":"admin","image":{"@type":"ImageObject","@id":"https:\/\/farmacija-mic.lv\/en\/zalu-nelabveliga-ietekme-uz-gremosanas-traktu-un-palidzibas-iespejas\/#authorImage","url":"https:\/\/secure.gravatar.com\/avatar\/be3221a6fac131657111728b4d912a877ec158b123d5db3afef3bd8a59784ece?s=96&d=mm&r=g","width":96,"height":96,"caption":"admin"}},{"@type":"WebPage","@id":"https:\/\/farmacija-mic.lv\/en\/zalu-nelabveliga-ietekme-uz-gremosanas-traktu-un-palidzibas-iespejas\/#webpage","url":"https:\/\/farmacija-mic.lv\/en\/zalu-nelabveliga-ietekme-uz-gremosanas-traktu-un-palidzibas-iespejas\/","name":"Z\u0101\u013cu nelabv\u0113l\u012bga ietekme uz gremo\u0161anas traktu un pal\u012bdz\u012bbas iesp\u0113jas - Medikamentu Inform\u0101cijas Centrs","description":"Aptuveni 40% z\u0101\u013cu nev\u0113lamo blak\u0146u skar gremo\u0161anas traktu. J\u0101\u0146em v\u0113r\u0101, ka gremo\u0161anas trakta darb\u012bbas trauc\u0113jumus var izrais\u012bt ne tikai peror\u0101li lietojamas z\u0101les, bet ar\u012b medikamenti, kas ievad\u012bti cit\u0101 veid\u0101. Iesp\u0113jamie meh\u0101nismi: \u2022 paredzama z\u0101\u013cu farmakolo\u0123isk\u0101s darb\u012bbas izpausme; \u2022 tie\u0161s g\u013cot\u0101das vai audu boj\u0101jums; \u2022 zarnu mikrobiotas izmai\u0146as; \u2022 iedarb\u012bba \u0101rpus gremo\u0161anas trakta ar sekund\u0101ru ietekmi","inLanguage":"en-US","isPartOf":{"@id":"https:\/\/farmacija-mic.lv\/en\/#website"},"breadcrumb":{"@id":"https:\/\/farmacija-mic.lv\/en\/zalu-nelabveliga-ietekme-uz-gremosanas-traktu-un-palidzibas-iespejas\/#breadcrumblist"},"author":{"@id":"https:\/\/farmacija-mic.lv\/en\/author\/admin\/#author"},"creator":{"@id":"https:\/\/farmacija-mic.lv\/en\/author\/admin\/#author"},"datePublished":"2026-09-15T11:58:21+03:00","dateModified":"2026-10-16T22:27:53+03:00"},{"@type":"WebSite","@id":"https:\/\/farmacija-mic.lv\/en\/#website","url":"https:\/\/farmacija-mic.lv\/en\/","name":"Medikamentu Inform\u0101cijas Centrs","description":"Farm\u0101cijas nozares port\u0101ls farmaceitiem un \u0101rstiem. Zi\u0146as, normat\u012bvie akti, pas\u0101kumi un t\u0101l\u0101kizgl\u012bt\u012bba vienuviet kop\u0161 2001. gada.","inLanguage":"en-US","publisher":{"@id":"https:\/\/farmacija-mic.lv\/en\/#organization"}}]},"og:locale":"en_US","og:site_name":"Medikamentu Inform\u0101cijas Centrs","og:type":"article","og:title":"Z\u0101\u013cu nelabv\u0113l\u012bga ietekme uz gremo\u0161anas traktu un pal\u012bdz\u012bbas iesp\u0113jas - Medikamentu Inform\u0101cijas Centrs","og:description":"Aptuveni 40% z\u0101\u013cu nev\u0113lamo blak\u0146u skar gremo\u0161anas traktu. J\u0101\u0146em v\u0113r\u0101, ka gremo\u0161anas trakta darb\u012bbas trauc\u0113jumus var izrais\u012bt ne tikai peror\u0101li lietojamas z\u0101les, bet ar\u012b medikamenti, kas ievad\u012bti cit\u0101 veid\u0101. Iesp\u0113jamie meh\u0101nismi: \u2022 paredzama z\u0101\u013cu farmakolo\u0123isk\u0101s darb\u012bbas izpausme; \u2022 tie\u0161s g\u013cot\u0101das vai audu boj\u0101jums; \u2022 zarnu mikrobiotas izmai\u0146as; \u2022 iedarb\u012bba \u0101rpus gremo\u0161anas trakta ar sekund\u0101ru ietekmi","og:url":"https:\/\/farmacija-mic.lv\/en\/zalu-nelabveliga-ietekme-uz-gremosanas-traktu-un-palidzibas-iespejas\/","article:published_time":"2026-09-15T09:58:21+00:00","article:modified_time":"2026-10-16T19:27:53+00:00","twitter:card":"summary_large_image","twitter:title":"Z\u0101\u013cu nelabv\u0113l\u012bga ietekme uz gremo\u0161anas traktu un pal\u012bdz\u012bbas iesp\u0113jas - Medikamentu Inform\u0101cijas Centrs","twitter:description":"Aptuveni 40% z\u0101\u013cu nev\u0113lamo blak\u0146u skar gremo\u0161anas traktu. J\u0101\u0146em v\u0113r\u0101, ka gremo\u0161anas trakta darb\u012bbas trauc\u0113jumus var izrais\u012bt ne tikai peror\u0101li lietojamas z\u0101les, bet ar\u012b medikamenti, kas ievad\u012bti cit\u0101 veid\u0101. Iesp\u0113jamie meh\u0101nismi: \u2022 paredzama z\u0101\u013cu farmakolo\u0123isk\u0101s darb\u012bbas izpausme; \u2022 tie\u0161s g\u013cot\u0101das vai audu boj\u0101jums; \u2022 zarnu mikrobiotas izmai\u0146as; \u2022 iedarb\u012bba \u0101rpus gremo\u0161anas trakta ar sekund\u0101ru ietekmi"},"aioseo_meta_data":{"post_id":"22902","title":null,"description":null,"keywords":null,"keyphrases":null,"focus_keyword":null,"additional_keywords":null,"truseo_locale":null,"primary_term":null,"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"default","og_image_custom_url":null,"og_image_custom_fields":null,"og_image_url":null,"og_image_width":null,"og_image_height":null,"og_video":null,"og_custom_url":null,"og_article_section":null,"og_article_tags":null,"twitter_use_og":false,"twitter_card":"default","twitter_image_type":"default","twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_image_url":null,"twitter_title":null,"twitter_description":null,"schema_type":"default","schema_type_options":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"","isEnabled":true},"graphs":[]},"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":null,"robots_max_videopreview":null,"robots_max_imagepreview":"large","priority":null,"frequency":null,"local_seo":null,"limit_modified_date":false,"ai":null,"breadcrumb_settings":null,"seo_analyzer_scan_date":null,"created":"2026-10-16 20:30:05","updated":"2026-10-16 20:30:05"},"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/farmacija-mic.lv\/en\/\" title=\"Home\">Home<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/farmacija-mic.lv\/category\/farmacijas-zinas\/\" title=\"Farm\u0101cija\">Farm\u0101cija<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\tZ\u0101\u013cu nelabv\u0113l\u012bga ietekme uz gremo\u0161anas traktu  un pal\u012bdz\u012bbas iesp\u0113jas\n\t\t<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"Home","link":"https:\/\/farmacija-mic.lv\/en\/"},{"label":"Farm\u0101cija","link":"https:\/\/farmacija-mic.lv\/category\/farmacijas-zinas\/"},{"label":"Z\u0101\u013cu nelabv\u0113l\u012bga ietekme uz gremo\u0161anas traktu  un pal\u012bdz\u012bbas iesp\u0113jas","link":"https:\/\/farmacija-mic.lv\/en\/zalu-nelabveliga-ietekme-uz-gremosanas-traktu-un-palidzibas-iespejas\/"}],"_links":{"self":[{"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/posts\/22902","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/comments?post=22902"}],"version-history":[{"count":1,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/posts\/22902\/revisions"}],"predecessor-version":[{"id":23046,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/posts\/22902\/revisions\/23046"}],"wp:attachment":[{"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/media?parent=22902"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/categories?post=22902"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/tags?post=22902"},{"taxonomy":"mic_flag","embeddable":true,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/mic_flag?post=22902"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}